Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal
- 31 December 2006
- journal article
- research article
- Published by Elsevier BV in Thrombosis Research
- Vol. 117 (5), 493-499
- https://doi.org/10.1016/j.thromres.2004.11.025
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial FibrillationThe New England Journal of Medicine, 2003
- Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous ThromboembolismThe New England Journal of Medicine, 2003
- Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous ThromboembolismThe New England Journal of Medicine, 2003
- Optimal Intensity of International Normalized Ratio in Warfarin Therapy for Secondary Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation.Internal Medicine, 2001
- Instability of Anticoagulation Intensity Contributes to Occurrence of Ischemic Stroke in Patients With Non-Rheumatic Atrial Fibrillation.Japanese Circulation Journal, 2001
- Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial FibrillationStroke, 2000
- Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillationThe American Journal of Cardiology, 1998
- An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial FibrillationThe New England Journal of Medicine, 1996
- Optimal Oral Anticoagulant Therapy in Patients with Nonrheumatic Atrial Fibrillation and Recent Cerebral IschemiaThe New England Journal of Medicine, 1995
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationThe New England Journal of Medicine, 1992